Page 1 | Search Results | Blood Advances | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clofarabine treatment of KMT2A r infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16

Tanja A. Gruber, Deqing Pei, John Choi, Cheng Cheng, Elaine Coustan-Smith, Dario Campana, Hope D. Swanson, Jennifer L. Pauley, Hiroto Inaba, Monika L. Metzger, Jeffrey E. Rubnitz, Raul C. Ribeiro, Susana C. Raimondi, Ching-Hon Pui, Sima Jeha

Blood Adv (2022) 6 (24): 6131–6134.

https://doi.org/10.1182/bloodadvances.2022008557

Published: 2022

Includes: Supplemental data

Journal Articles

Chimeric antigen receptor–T cells with cytokine neutralizing capacity

Adrian H. J. Tan, Natasha Vinanica, Dario Campana

Blood Adv (2020) 4 (7): 1419–1431.

https://doi.org/10.1182/bloodadvances.2019001287

Published: 2020

Includes: Supplemental data

Journal Articles

A novel method to generate T-cell receptor–deficient chimeric antigen receptor T cells

Takahiro Kamiya, Desmond Wong, Yi Tian Png, Dario Campana

Blood Adv (2018) 2 (5): 517–528.

https://doi.org/10.1182/bloodadvances.2017012823

Published: 2018

Includes: Supplemental data

Journal Articles

Feasibility of minimal residual disease studies by multiparametric flow cytometry for acute myeloid leukemia in a developing country

Lorena Lobo de Figueiredo-Pontes, Maria Isabel Ayrosa Madeira, Luisa Koury Corrêa de Araujo, Priscila Santos Scheucher, Fabíola Traina, Ana Silvia Gouvêa de Lima, Katia Pagnano, Ronald Pallota, Rosane Bittencourt, Maria de Lourdes Chauffaille, Marcos Roberto Pedron Oltramari, Marcia Higashi, Rodrigo Miguel Bendlin, Elaine Coustan-Smith, Dario Campana, Eduardo Magalhães Rego

Blood Adv (2017) 1 (Suppl): 80–83.

https://doi.org/10.1182/bloodadvances.2017GS102444

Published: 2017

Journal Articles

Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies

Yi Tian Png, Natasha Vinanica, Takahiro Kamiya, Noriko Shimasaki, Elaine Coustan-Smith, Dario Campana

Blood Adv (2017) 1 (25): 2348–2360.

https://doi.org/10.1182/bloodadvances.2017009928

Published: 2017

Includes: Supplemental data

NARROW

Clofarabine treatment of KMT2A r infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16

Chimeric antigen receptor–T cells with cytokine neutralizing capacity

A novel method to generate T-cell receptor–deficient chimeric antigen receptor T cells

Feasibility of minimal residual disease studies by multiparametric flow cytometry for acute myeloid leukemia in a developing country

Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies

Email alerts

ASH Publications

American Society of Hematology

Clofarabine treatment of KMT2A r infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16

Chimeric antigen receptor–T cells with cytokine neutralizing capacity

A novel method to generate T-cell receptor–deficient chimeric antigen receptor T cells

Feasibility of minimal residual disease studies by multiparametric flow cytometry for acute myeloid leukemia in a developing country

Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only